PT Kalbe Farma Tbk. (IDX:KLBF)
Indonesia · Delayed Price · Currency is IDR 765.00
-20.00 (-2.55%)
Oct 12, 2026, 4:13 PM WIB
PT Kalbe Farma Tbk. Ratios and Metrics
Market cap in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 34,615,378 | 54,605,720 | 62,762,886 | 74,471,583 | 96,674,291 | 75,699,810 | |
Market Cap Growth | -28.06% | -13.00% | -15.72% | -22.97% | 27.71% | 9.12% |
Enterprise Value | 31,891,584 | 52,752,876 | 60,918,444 | 74,288,291 | 95,125,197 | 72,008,811 |
Last Close Price | 785.00 | 1171.99 | 1292.02 | 1498.93 | 1911.10 | 1445.05 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.87 | 14.90 | 19.37 | 26.92 | 28.58 | 23.78 |
Forward PE | 9.55 | 14.58 | 18.65 | 19.72 | 25.34 | 22.83 |
PS Ratio | 0.94 | 1.55 | 1.92 | 2.45 | 3.34 | 2.88 |
PB Ratio | 1.38 | 2.21 | 2.55 | 3.22 | 4.38 | 3.56 |
P/TBV Ratio | 1.61 | 2.60 | 3.07 | 3.79 | 5.12 | 4.10 |
P/FCF Ratio | 14.84 | 21.46 | 16.19 | 36.75 | 170.67 | 32.60 |
P/OCF Ratio | 11.02 | 16.70 | 13.12 | 25.61 | 76.01 | 26.79 |
PEG Ratio | 0.85 | 1.33 | 1.51 | 1.23 | 1.86 | 2.22 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.87 | 1.49 | 1.87 | 2.44 | 3.29 | 2.74 |
EV/EBITDA Ratio | 6.37 | 9.89 | 12.65 | 17.22 | 19.38 | 15.49 |
EV/EBIT Ratio | 6.98 | 11.52 | 14.85 | 20.36 | 22.39 | 17.86 |
EV/FCF Ratio | 13.70 | 20.73 | 15.71 | 36.66 | 167.94 | 31.01 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.03 | 0.01 | 0.02 | 0.03 | 0.05 | 0.03 |
Debt / EBITDA Ratio | 0.16 | 0.06 | 0.12 | 0.14 | 0.24 | 0.13 |
Debt / FCF Ratio | 0.35 | 0.12 | 0.14 | 0.31 | 2.06 | 0.27 |
Net Debt / Equity Ratio | -0.16 | -0.17 | -0.17 | -0.12 | -0.13 | -0.28 |
Net Debt / EBITDA Ratio | -0.82 | -0.78 | -0.89 | -0.64 | -0.60 | -1.26 |
Net Debt / FCF Ratio | -1.74 | -1.64 | -1.11 | -1.37 | -5.17 | -2.52 |
Asset Turnover | 1.21 | 1.18 | 1.16 | 1.12 | 1.09 | 1.09 |
Inventory Turnover | 3.17 | 3.19 | 2.96 | 2.68 | 2.83 | 3.40 |
Quick Ratio | 1.78 | 1.95 | 2.36 | 2.53 | 2.01 | 2.84 |
Current Ratio | 3.15 | 3.47 | 4.11 | 4.91 | 3.77 | 4.45 |
Return on Equity (ROE) | 14.77% | 15.18% | 13.61% | 12.29% | 15.91% | 16.35% |
Return on Assets (ROA) | 9.22% | 9.52% | 9.08% | 8.40% | 10.04% | 10.45% |
Return on Invested Capital (ROIC) | 16.72% | 17.45% | 15.41% | 14.14% | 18.91% | 21.20% |
Return on Capital Employed (ROCE) | 17.50% | 18.10% | 16.20% | 15.30% | 18.60% | 18.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 10.16% | 6.71% | 5.16% | 3.72% | 3.50% | 4.21% |
FCF Yield | 6.74% | 4.66% | 6.18% | 2.72% | 0.59% | 3.07% |
Dividend Yield | 2.61% | 1.71% | 2.79% | 2.07% | 1.99% | 2.42% |
Payout Ratio | 25.07% | 44.63% | 44.25% | 63.53% | 48.23% | 41.23% |
Buyback Yield / Dilution | 0.91% | 1.43% | 0.15% | 0.56% | 0.76% | 0.00% |
Total Shareholder Return | 3.44% | 3.14% | 2.94% | 2.63% | 2.75% | 2.42% |